Introduction
Patients with recurrent respiratory problems, particularly chronic obstructive airways disease are at substantial risk of developing acute respiratory failure, a complication which carries with it a high morbidity and mortality.
It has been known for many years that drugs which depress central nervous system activity, such as narcotic analgesics, hypnotics and anxiolytic agents may precipitate the development of respiratory failure in such patients (Wilson, Hoseth and Dempsey, 1954) . Nevertheless, this hazard seems to be insufficiently appreciated and these drugs continue to be used in patients with severe respiratory disease. In order to obtain an estimate of the frequency with which patients with (Kronenberg et al., 1975) . Also the observation that there is a wide range of ventilatory responses to a given carbon dioxide stimulus both in healthy subjects (Irsigler, 1976) and in those with respiratory disease, is consistent with the proposition that patients might well vary considerably in respect of carbon dioxide retention following the administration of drugs with some respiratory-depressant properties.
